Skip to main content
Top
Published in: Current Fungal Infection Reports 3/2016

01-09-2016 | Fungal Infections of Skin and Subcutaneous Tissue (A Bonifaz, Section Editor)

Pityriasis Versicolor: Clinical Spectrum and Diagnosis

Author: Jose Manuel Rios-Yuil

Published in: Current Fungal Infection Reports | Issue 3/2016

Login to get access

Abstract

Pityriasis versicolor (PV) is caused by the fungus Malassezia, especially by Malassezia globosa. The predisposing factors for PV are heat, humidity, hyperhidrosis, oral contraceptives, stress, application of oily preparations, and treatment with corticosteroids. PV is found mainly on the seborrheic areas of the trunk, shoulders, upper aspects of the arms, and neck, but it may spread to the face, scalp, submammary areas, axillae, groin, skin folds, and buttocks. It is characterized by hyperpigmented, hypopigmented, or erythematous (versicolor), round-to-oval, finely scaling, thin plaques. Other less frequent clinical variants are papular, atrophic, imbricata, and pityriasis rubra pilaris-like presentations. The diagnosis of PV is usually made clinically with the aid of Wood’s light or dermoscopy. Direct microscopic examination, culture, biopsy, and molecular studies are among the laboratory diagnostic methods. Topical therapy is the treatment of choice for most patients. Systemic imidazole therapy is usually reserved for widespread or resistant cases.
Literature
1.
go back to reference Pedrosa AF, Lisboa C, Gonçalves RA. Malassezia infections: a medical conundrum. J Am Acad Dermatol. 2014;71:170–6.CrossRefPubMed Pedrosa AF, Lisboa C, Gonçalves RA. Malassezia infections: a medical conundrum. J Am Acad Dermatol. 2014;71:170–6.CrossRefPubMed
3.
go back to reference Santana JO, Azevedo FL, Campos Filho PC. Pityriasis versicolor: clinical-epidemiological characterization of patients in the urban area of Buerarema-BA, Brazil. An Bras Dermatol. 2013;88:216–21.CrossRefPubMedPubMedCentral Santana JO, Azevedo FL, Campos Filho PC. Pityriasis versicolor: clinical-epidemiological characterization of patients in the urban area of Buerarema-BA, Brazil. An Bras Dermatol. 2013;88:216–21.CrossRefPubMedPubMedCentral
4.
go back to reference Rodoplu G, Saracli MA, Gümral R, Taner YS. Distribution of Malassezia species in patients with pityriasis versicolor in Turkey. J Mycol Med. 2014;24:117–23.CrossRefPubMed Rodoplu G, Saracli MA, Gümral R, Taner YS. Distribution of Malassezia species in patients with pityriasis versicolor in Turkey. J Mycol Med. 2014;24:117–23.CrossRefPubMed
5.
go back to reference Metin A, Dilek N, Demirseven DD. Fungal infections of the folds (intertriginous areas). Clin Dermatol. 2015;33:437–47.CrossRefPubMed Metin A, Dilek N, Demirseven DD. Fungal infections of the folds (intertriginous areas). Clin Dermatol. 2015;33:437–47.CrossRefPubMed
6.
go back to reference Harada K, Saito M, Sugita T, Tsuboi R. Malassezia species and their associated skin diseases. J Dermatol. 2015;42:250–7.CrossRefPubMed Harada K, Saito M, Sugita T, Tsuboi R. Malassezia species and their associated skin diseases. J Dermatol. 2015;42:250–7.CrossRefPubMed
8.
go back to reference Heidrich D, Daboit TC, Stopiglia CD, Magagnin CM, Vetoratto G, Amaro TG, et al. Sixteen years of pityriasis versicolor in metropolitan area of Porto Alegre, Southern Brazil. Rev Inst Med Trop Sao Paulo. 2015;57:277–80.CrossRefPubMedPubMedCentral Heidrich D, Daboit TC, Stopiglia CD, Magagnin CM, Vetoratto G, Amaro TG, et al. Sixteen years of pityriasis versicolor in metropolitan area of Porto Alegre, Southern Brazil. Rev Inst Med Trop Sao Paulo. 2015;57:277–80.CrossRefPubMedPubMedCentral
9.
go back to reference Hawkins DM, Smidt AC. Superficial fungal infections in children. Pediatr Clin North Am. 2014;61:443–55.CrossRefPubMed Hawkins DM, Smidt AC. Superficial fungal infections in children. Pediatr Clin North Am. 2014;61:443–55.CrossRefPubMed
10.••
go back to reference Kallini JR, Riaz F, Khachemoune A. Tinea versicolor in dark-skinned individuals. Int J Dermatol. 2014;53:137–41. Only few articles on the manifestation of skin diseases on dark skin.CrossRefPubMed Kallini JR, Riaz F, Khachemoune A. Tinea versicolor in dark-skinned individuals. Int J Dermatol. 2014;53:137–41. Only few articles on the manifestation of skin diseases on dark skin.CrossRefPubMed
11.••
go back to reference Varada S, Dabade T, Loo DS. Uncommon presentations of tinea versicolor. Dermatol Pract Concept. 2014;4:93–6. It is important to know the less frequent presentations of PV.CrossRefPubMedPubMedCentral Varada S, Dabade T, Loo DS. Uncommon presentations of tinea versicolor. Dermatol Pract Concept. 2014;4:93–6. It is important to know the less frequent presentations of PV.CrossRefPubMedPubMedCentral
12.•
13.
go back to reference Blasco-Morente G, Garrido-Colmenero C, Pérez López I, Tercedor-Sánchez J. Wood’ light in dermatology: an essential technique. PIEL [Barc]. 2014;29:487–94.CrossRef Blasco-Morente G, Garrido-Colmenero C, Pérez López I, Tercedor-Sánchez J. Wood’ light in dermatology: an essential technique. PIEL [Barc]. 2014;29:487–94.CrossRef
14.•
go back to reference Romano C, Feci L, Mancianti F, Fimiani M. Perineal and genital pityriasis versicolor due to Malassezia globosa. J Eur Acad Dermatol Venereol. 2015;29:1857–8. Rare variants that might be misdiagnosed if not known.CrossRefPubMed Romano C, Feci L, Mancianti F, Fimiani M. Perineal and genital pityriasis versicolor due to Malassezia globosa. J Eur Acad Dermatol Venereol. 2015;29:1857–8. Rare variants that might be misdiagnosed if not known.CrossRefPubMed
15.
go back to reference Didehdar M, Mehbod AS, Eslamirad Z, Mosayebi M, Hajihossein R, Ghorbanzade B, et al. Identification of Malassezia species isolated from patients with pityriasis versicolor using PCR-RFLP method in Markazi Province, Central Iran. Iran J Public Health. 2014;43:682–6.PubMedPubMedCentral Didehdar M, Mehbod AS, Eslamirad Z, Mosayebi M, Hajihossein R, Ghorbanzade B, et al. Identification of Malassezia species isolated from patients with pityriasis versicolor using PCR-RFLP method in Markazi Province, Central Iran. Iran J Public Health. 2014;43:682–6.PubMedPubMedCentral
16.
go back to reference Talaee R, Katiraee F, Ghaderi M, Erami M, Kazemi Alavi A, Nazeri M. Molecular identification and prevalence of Malassezia species in pityriasis versicolor patients from Kashan, Iran. Jundishapur J Microbiol. 2014;7:e11561.CrossRefPubMedPubMedCentral Talaee R, Katiraee F, Ghaderi M, Erami M, Kazemi Alavi A, Nazeri M. Molecular identification and prevalence of Malassezia species in pityriasis versicolor patients from Kashan, Iran. Jundishapur J Microbiol. 2014;7:e11561.CrossRefPubMedPubMedCentral
17.
go back to reference Rad F, Nik-Khoo B, Yaghmaee R, Gharibi F. Terbinafine 1% cream and ketoconazole 2% cream in the treatment of pityriasis versicolor: a randomized comparative clinical trial. Pak J Med Sci. 2014;30:1273–6.PubMedPubMedCentral Rad F, Nik-Khoo B, Yaghmaee R, Gharibi F. Terbinafine 1% cream and ketoconazole 2% cream in the treatment of pityriasis versicolor: a randomized comparative clinical trial. Pak J Med Sci. 2014;30:1273–6.PubMedPubMedCentral
18.
go back to reference Ibekwe PU, Ogunbiyi AO, Besch R, Ruzicka T, Sárdy M. The spectrum of Malassezia species isolated from students with pityriasis vesicolor in Nigeria. Mycoses. 2015;58:203–8.CrossRefPubMed Ibekwe PU, Ogunbiyi AO, Besch R, Ruzicka T, Sárdy M. The spectrum of Malassezia species isolated from students with pityriasis vesicolor in Nigeria. Mycoses. 2015;58:203–8.CrossRefPubMed
19.••
go back to reference Zhou H, Tang XH, De Han J, Chen MK. Dermoscopy as an ancillary tool for the diagnosis of pityriasis versicolor. J Am Acad Dermatol. 2015;73:e205–6. A new ancillary tool for diagnosis.CrossRefPubMed Zhou H, Tang XH, De Han J, Chen MK. Dermoscopy as an ancillary tool for the diagnosis of pityriasis versicolor. J Am Acad Dermatol. 2015;73:e205–6. A new ancillary tool for diagnosis.CrossRefPubMed
20.
go back to reference Payle B, Serrano L, Bieley HC, Reyes BA. Albert’s solution versus potassium hydroxide solution in the diagnosis of tinea versicolor. Int J Dermatol. 1994;33:182–3.CrossRefPubMed Payle B, Serrano L, Bieley HC, Reyes BA. Albert’s solution versus potassium hydroxide solution in the diagnosis of tinea versicolor. Int J Dermatol. 1994;33:182–3.CrossRefPubMed
21.•
go back to reference del Boz J, Padilla-España L, Crespo-Erchiga V. Sample taking and direct examination in dermatomycoses. Actas Dermosifiliogr. 2016;107:65–7. Highlights the importance of correct sampling for direct examination.CrossRefPubMed del Boz J, Padilla-España L, Crespo-Erchiga V. Sample taking and direct examination in dermatomycoses. Actas Dermosifiliogr. 2016;107:65–7. Highlights the importance of correct sampling for direct examination.CrossRefPubMed
Metadata
Title
Pityriasis Versicolor: Clinical Spectrum and Diagnosis
Author
Jose Manuel Rios-Yuil
Publication date
01-09-2016
Publisher
Springer US
Published in
Current Fungal Infection Reports / Issue 3/2016
Print ISSN: 1936-3761
Electronic ISSN: 1936-377X
DOI
https://doi.org/10.1007/s12281-016-0261-6

Other articles of this Issue 3/2016

Current Fungal Infection Reports 3/2016 Go to the issue

Fungal Infections of Skin and Subcutaneous Tissue (A Bonifaz, Section Editor)

Review on Tinea Incognita

Advances in Diagnosis of Invasive Fungal Infections (S Chen, Section Editor)

Diagnosis of Midwestern Endemic Mycoses

Fungal Infections of Skin and Subcutaneous Tissue (A Bonifaz, Section Editor)

Primary and Disseminated Cutaneous Coccidioidomycosis: Clinical Aspects and Diagnosis

Fungal Infections of Skin and Subcutaneous Tissue (A Bonifaz, Section Editor)

Sporotrichosis in Children: an Update

Advances in Diagnosis of Invasive Fungal Infections (S Chen, Section Editor)

Azole Resistance in Moulds—Approach to Detection in a Clinical Laboratory

Fungal Infections of Skin and Subcutaneous Tissue (A Bonifaz, Section Editor)

Clinical Focus on Malassezia Folliculitis

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine